Long-term response of refractory primary cold agglutinin disease to eculizumab therapy

被引：20
作者：
Gupta, Neha [1 ,3 ]
Wang, Eunice S. [2 ]
机构：
[1] SUNY Buffalo, Dept Med, Buffalo, NY 14202 USA
[2] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA
[3] SUNY Buffalo, Dept Internal Med, Buffalo, NY 14202 USA
来源：
ANNALS OF HEMATOLOGY | 2014年 / 93卷 / 02期
关键词：
COMPLEMENT; RITUXIMAB;
D O I：
10.1007/s00277-013-1800-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：343 / 344
页数：2
相关论文
共 7 条
[1]   Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients [J].
Berentsen, S ;
Ulvestad, E ;
Gjertsen, BT ;
Hjorth-Hansen, H ;
Langholm, R ;
Knutsen, H ;
Ghanima, W ;
Shammas, FV ;
Tjonnfjord, GE .
BLOOD, 2004, 103 (08) :2925-2928
[2]   CHLORAMBUCIL TREATMENT OF PATIENTS WITH COLD AGGLUTININ SYNDROME [J].
HIPPE, E ;
JENSEN, KB ;
OLESEN, H ;
LIND, K ;
THOMSEN, PEB .
BLOOD-THE JOURNAL OF HEMATOLOGY, 1970, 35 (01) :68-&
[3]  
Karasawa M, 2008, JPN J CLIN MED, V66, P520
[4]  
KIRSCHFINK M, 1994, INFUSIONSTHERAPIE, V21, P405
[5]   Cold agglutinine disease [J].
Roeth, Alexander ;
Duehrsen, Ulrich .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 84 (01) :91-91
[6]   Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin disease [J].
Roeth, Alexander ;
Huettmann, Andreas ;
Rother, Russell P. ;
Duehrsen, Ulrich ;
Philipp, Thomas .
BLOOD, 2009, 113 (16) :3885-3886
[7]   Rituximab in chronic cold agglutinin disease:: a prospective study of 20 patients [J].
Schöllkopf, C ;
Kjeldsen, L ;
Bjerrum, OW ;
Mourits-Andersen, HT ;
Nielsen, JL ;
Christensen, BE ;
Jensen, BA ;
Pedersen, BB ;
Taaning, EB ;
Klausen, TW ;
Birgens, H .
LEUKEMIA & LYMPHOMA, 2006, 47 (02) :253-260
1